Zealand Pharma A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0060257814
DKK
508.00
14.5 (2.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Zealand Pharma A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,083.00
-708.00
-972.00
-758.00
-839.00
-576.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
122.00
52.00
-57.00
-196.00
54.00
150.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-930.00
-425.00
-942.00
-1,211.00
-688.00
-408.00
Cash Flow from Investing Activities
-7,332.00
-1,094.00
281.00
-18.00
-196.00
-52.00
Cash Flow from Financing Activities
8,288.00
907.00
587.00
1,332.00
760.00
674.00
Net Cash Inflow / Outflow
30.00
-619.00
-59.00
168.00
-120.00
220.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
6.00
-7.00
13.00
66.00
3.00
7.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Zealand Pharma A/S
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
-1083.445
3719
-4,802.00
-129.13%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
122.379
-2889
3,011.00
104.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-930.816
3403
-4,333.00
-127.35%
Cash Flow from Investing Activities
-7332.915
-15286
7,954.00
52.03%
Cash Flow from Financing Activities
8288.491
11552
-3,264.00
-28.25%
Net Cash Inflow / Outflow
30.992
-346
376.00
108.96%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
6.232
-15
21.00
141.55%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -118.67% vs 54.82% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-930.82
-425.67
-118.67%